Fortrea Holdings Inc. Common Stock

FTRE · Medical Laboratories · $1.9B
Powering up
FTRE
$19.93
▼ −1.73%
09/18 O 20.10 H 20.22 L 19.28 C 19.93 ▼ −1.73%
Vol 3.1M RS 93
RS rating93
Now vs pivot (%)−6.83%
Tightening (ATR ratio)1.44×
Volume dry-up1.16×
Up/down volume, net0.05
From 52-week high7%
forming
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 7.4 weeks and fell 25% from its ceiling at its deepest. The pivot is $21.39, and the stock closed 6.8% below it. Its relative strength rating is 93.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
  1. Earningstentativein 48d
    Quarterly earnings
    Nov 5, 2026
Flagged by the market sweep
GappedTape · 2026-09-16
+13.3%
A director or officer changedFiling · 2026-09-11
5.02

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Fortrea Holdings Inc. Common Stock (FTRE) — The Tape